Randomized Phase III Study Comparing Paclitaxel/Cisplatin/ Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer Without Prior Systemic Therapy: EORTC Intergroup Study 30987

PURPOSE: The combination of gemcitabine plus cisplatin (GC) is a standard regimen in patients with locally advanced or metastatic urothelial cancer. A phase I/II study suggested that a three-drug regimen that included paclitaxel had greater antitumor activity and might improve survival. PATIENTS AND...

詳細記述

保存先:
書誌詳細
主要な著者: Bellmunt, Joaquim, von der Maase, Hans, Mead, Graham M., Skoneczna, Iwona, De Santis, Maria, Daugaard, Gedske, Boehle, Andreas, Chevreau, Christine, Paz-Ares, Luis, Laufman, Leslie R., Winquist, Eric, Raghavan, Derek, Marreaud, Sandrine, Collette, Sandra, Sylvester, Richard, de Wit, Ronald
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Clinical Oncology 2012
主題:
Original Reports
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3341152/
https://ncbi.nlm.nih.gov/pubmed/22370319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.38.6979
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料